In Segment A, members will receive distinctive doses and schedules of oral ABBV-744 tablet to discover Secure dosing routine. Supplemental participants might be enrolled at the recognized monotherapy dosign routine. In Section B, contributors will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In Segment C, https://walesm766zkv9.bloginder.com/profile